Devyser Debuts 2 Genetic Test Kits for Hereditary Cancer
Devyser LynchFAP and Devyser BRCA PALB2 genetic test kits offer efficient, targeted analysis of genes associated with increased cancer risk.
Read MorePosted by Melanie Hamilton-Basich | Jul 3, 2023 | Breast, Colorectal |
Devyser LynchFAP and Devyser BRCA PALB2 genetic test kits offer efficient, targeted analysis of genes associated with increased cancer risk.
Read MorePosted by Chris Wolski | Jul 3, 2023 | Kidney Disease |
The AACC, in collaboration with the NKF, has released guidance to reduce racial and gender disparities in the care of chronic kidney disease.
Read MorePosted by Melanie Hamilton-Basich | Jun 29, 2023 | Diagnostic Technologies |
VeraBIND technology offers a bead-based solution that improves the accuracy of biomarker detection and minimizes the occurrence of false positive or negative results across various sample types.
Read MorePosted by Chris Wolski | Jun 28, 2023 | Immunoassay Instrumentation |
Researchers have developed a time and cost-efficient digital assay that can directly measure HIV viral load in single drop of blood.
Read MorePosted by Melanie Hamilton-Basich | Jun 22, 2023 | Cancer, Sequencing Systems |
The new DM-Seq technique allows for scientists to profile DNA using very small samples and without damaging the sample.
Read More